Literature DB >> 12049486

Ocular tolerance of absorption enhancers in ophthalmic preparations.

Pascal Furrer1, Joachim Michael Mayer, Bernard Plazonnet, Robert Gurny.   

Abstract

The use of absorption promoters is a way to improve the bioavailability and therapeutic response of topically applied ophthalmic drugs. The ocular tolerance of 9 potential absorption promoters was investigated as well as the influence of the enhancers' concentration on the ocular tolerance. The substances tested were instillated repetitively (4 times per day, during 3 days, and once just before examination) as aqueous solutions onto rabbit corneas. Fluorescein dyeing enabled us to specifically mark corneal damage that was observed by confocal microscopy. The degree of corneal injury was assessed with an image-processing system that calculated the total fluorescent areas. Confocal microscopy results showed the relatively good tolerance of permeation enhancers like dimethyl sulfoxide (DMSO), decamethonium, edetate, glycocholate, and cholate in contrast to the poorly tolerated saponin and fusidate. Increasing the promoters' concentration led generally to an increase in corneal lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049486      PMCID: PMC2751287          DOI: 10.1208/ps040102

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  15 in total

Review 1.  Enhancement of ocular drug penetration.

Authors:  H Sasaki; K Yamamura; T Mukai; K Nishida; J Nakamura; M Nakashima; M Ichikawa
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1999       Impact factor: 4.889

Review 2.  Confocal microscopy as a tool for the investigation of the anterior part of the eye.

Authors:  P Furrer; J M Mayer; R Gurny
Journal:  J Ocul Pharmacol Ther       Date:  1997-12       Impact factor: 2.671

Review 3.  Topical ocular drug delivery: recent developments and future challenges.

Authors:  V H Lee; J R Robinson
Journal:  J Ocul Pharmacol       Date:  1986

4.  Micropunctate fluorescein staining of the human corneal surface: microerosions or cystic spaces? A non-contact photomicrographic in vivo study.

Authors:  H M Tabery
Journal:  Acta Ophthalmol Scand       Date:  1997-04

5.  Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines.

Authors:  S Burgalassi; P Chetoni; D Monti; M F Saettone
Journal:  Toxicol Lett       Date:  2001-05-31       Impact factor: 4.372

6.  Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.

Authors:  O Felt; P Furrer; J M Mayer; B Plazonnet; P Buri; R Gurny
Journal:  Int J Pharm       Date:  1999-04-15       Impact factor: 5.875

7.  Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.

Authors:  P Furrer; B Plazonnet; J M Mayer; R Gurny
Journal:  Int J Pharm       Date:  2000-10-10       Impact factor: 5.875

8.  Ophthalmic preservatives as absorption promoters for ocular drug delivery.

Authors:  H Sasaki; T Nagano; K Yamamura; K Nishida; J Nakamura
Journal:  J Pharm Pharmacol       Date:  1995-09       Impact factor: 3.765

9.  Delivery of systemic regular insulin via the ocular route in cats.

Authors:  R V Morgan
Journal:  J Ocul Pharmacol Ther       Date:  1995       Impact factor: 2.671

10.  Improvement of systemic absorption of insulin through eyes with absorption enhancers.

Authors:  G C Chiou; C Y Chuang
Journal:  J Pharm Sci       Date:  1989-10       Impact factor: 3.534

View more
  11 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  Corneal permeability assay of topical eye drop solutions in rabbits by MRI.

Authors:  Xiaochun Mao; Shaowei Zhang; Hui Hen; Longting Du; Guigang Li; Bin Li; Hong Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells.

Authors:  Adrian Smedowski; Jussi J Paterno; Elisa Toropainen; Debasish Sinha; Edward Wylegala; Kai Kaarniranta
Journal:  J Biochem Pharmacol Res       Date:  2014-12-01

Review 4.  Nanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery.

Authors:  Jean Kim; Erica B Schlesinger; Tejal A Desai
Journal:  Ther Deliv       Date:  2015

5.  Corneal antinociceptive effect of (-)-α-bisabolol.

Authors:  Gisele Façanha Diógenes Teixeira; Flávio Nogueira da Costa; Adriana Rolim Campos
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 6.  Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System.

Authors:  Jinxiu Li; Qian Xie; Rong Ma; Yong Li; Jianmei Yuan; Mihong Ren; Hongyan Li; Jiajun Wang; Danni Lu; Zhuo Xu; Jian Wang
Journal:  Front Med (Lausanne)       Date:  2021-11-25

7.  The Effect of Diluted Penetration Enhancer in Nebulized Mist versus Liquid Drop Preparation Forms on Retrobulbar Blood Flow in Healthy Human Subjects.

Authors:  Sally Primus; Ingrida Januleviciene; Brent Siesky; Austin Gerber; Patrick Egan; Annahita Amireskandari; Lina Siaudvytyte; Ruta Barsauskaite; Alon Harris
Journal:  Pharmaceutics       Date:  2012-08-08       Impact factor: 6.321

8.  Ophthalmic drug delivery in glaucoma-a review.

Authors:  Ingrida Januleviciene; Lina Siaudvytyte; Ruta Barsauskaite
Journal:  Pharmaceutics       Date:  2012-03-21       Impact factor: 6.321

Review 9.  Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents.

Authors:  Eliana B Souto; João Dias-Ferreira; Ana López-Machado; Miren Ettcheto; Amanda Cano; Antonio Camins Espuny; Marta Espina; Maria Luisa Garcia; Elena Sánchez-López
Journal:  Pharmaceutics       Date:  2019-09-06       Impact factor: 6.321

Review 10.  Contact Lenses as Ophthalmic Drug Delivery Systems: A Review.

Authors:  Paola Franco; Iolanda De Marco
Journal:  Polymers (Basel)       Date:  2021-03-30       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.